Cargando…

Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care

OBJECTIVE: To investigate the associations between direct oral anticoagulants (DOACs) and risks of bleeding, ischaemic stroke, venous thromboembolism, and all cause mortality compared with warfarin. DESIGN: Prospective open cohort study. SETTING: UK general practices contributing to QResearch or Cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vinogradova, Yana, Coupland, Carol, Hill, Trevor, Hippisley-Cox, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031213/ https://www.ncbi.nlm.nih.gov/pubmed/29973392 http://dx.doi.org/10.1136/bmj.k2505

Ejemplares similares

Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2015)

Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case–control studies using the QResearch and the CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2014)

Exposure to statins and risk of common cancers: a series of nested case-control studies
por: Vinogradova, Yana, et al.
Publicado: (2011)

Exposure to bisphosphonates and risk of cancer: a protocol for nested case–control studies using the QResearch primary care database
por: Vinogradova, Yana, et al.
Publicado: (2012)

Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data
por: Vinogradova, Yana, et al.
Publicado: (2013)

Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2019)

Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2020)

Patients who discontinued statin treatment: a protocol for cohort study using primary care data
por: Vinogradova, Yana, et al.
Publicado: (2015)

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
por: Vinogradova, Yana, et al.
Publicado: (2016)

Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
por: Hippisley-Cox, Julia, et al.
Publicado: (2014)

Real-world monitoring of direct oral anticoagulants in clinic and hospitalization settings
por: Takatsuki, Seiji, et al.
Publicado: (2017)

Use of menopausal hormone therapy and risk of dementia: nested case-control studies using QResearch and CPRD databases
por: Vinogradova, Yana, et al.
Publicado: (2021)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Patient-specific and healthcare real-world costs of atrial fibrillation in individuals treated with direct oral anticoagulant agents or warfarin
por: Pyykönen, Mikko, et al.
Publicado: (2021)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

Effect of Gene-Based Warfarin Dosing on Anticoagulation Control and Clinical Events in a Real-World Setting
por: Zhang, Jinhua, et al.
Publicado: (2020)

Direct oral anticoagulants versus warfarin: is new always better than the old?
por: Burn, John, et al.
Publicado: (2018)

Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin
por: Kurogi, Ryota, et al.
Publicado: (2018)

Exposure to cyclooxygenase-2 inhibitors and risk of cancer: nested case–control studies
por: Vinogradova, Y, et al.
Publicado: (2011)

Exposure to bisphosphonates and risk of common non-gastrointestinal cancers: series of nested case–control studies using two primary-care databases
por: Vinogradova, Y, et al.
Publicado: (2013)

Correction: Direct oral anticoagulants versus warfarin: is new always better than the old?
Publicado: (2018)

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valve Replacement or Repair
por: Mentias, Amgad, et al.
Publicado: (2022)

Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
por: Adachi, Tomohide, et al.
Publicado: (2017)

Dental extractions on direct oral anticoagulants vs. warfarin: The DENTST study
por: Brennan, Yvonne, et al.
Publicado: (2020)

Outcomes in patients undergoing periprocedural interruption of warfarin or direct oral anticoagulants
por: Lee, Jeffrey, et al.
Publicado: (2022)

Impact of anticoagulants on the clinical outcomes of colonic diverticular bleeding comparing warfarin and direct oral anticoagulants
por: Chang, Li-sa, et al.
Publicado: (2022)

Real-world comparison of non-vitamin K antagonist oral anticoagulants and warfarin in Asian octogenarian patients with atrial fibrillation
por: Kwon, Chang Hee, et al.
Publicado: (2016)

The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review
por: Elango, Kalaimani, et al.
Publicado: (2021)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
por: Abdelnabi, Mahmoud, et al.
Publicado: (2022)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Asians With Atrial Fibrillation: Meta-Analysis of Randomized Trials and Real-World Studies
por: Xue, Zhengbiao, et al.
Publicado: (2019)

Atrial fibrillation bleeding risk and prediction while treated with direct oral anticoagulants in warfarin‐naïve or warfarin‐experienced patients
por: Perino, Alexander C., et al.
Publicado: (2022)

Acute and Delayed Intracranial Hemorrhage in Head-Injured Patients on Warfarin versus Direct Oral Anticoagulant Therapy
por: Hughes, Patrick G., et al.
Publicado: (2021)

Comparative effectiveness and safety of direct oral anticoagulants versus warfarin among patients with recurrent venous thromboembolism
por: Kang, Hye‐Rim, et al.
Publicado: (2023)

Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney disease
por: Hsu, Chia-Chen, et al.
Publicado: (2023)

A surgeon's guide to anticoagulant and antiplatelet medications part one: warfarin and new direct oral anticoagulant medications
por: McBeth, Paul B, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ljoi6np4tquijc6mrk4mtfo4tm